topiramate

NDC 68382-139 · Zydus Pharmaceuticals USA Inc.

Generic nametopiramate

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)TOPIRAMATE

Strength50 mg/1

Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]

Marketing categoryANDA

Packages

68382-139-01 — 100 TABLET, FILM COATED in 1 BOTTLE (68382-139-01)

68382-139-05 — 500 TABLET, FILM COATED in 1 BOTTLE (68382-139-05)

68382-139-14 — 60 TABLET, FILM COATED in 1 BOTTLE (68382-139-14)

68382-139-16 — 90 TABLET, FILM COATED in 1 BOTTLE (68382-139-16)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68071-4760 — topiramate, 68071-4877 — topiramate, 68071-5165 — Topiramate, 68084-342 — Topiramate, 68084-343 — Topiramate, 68084-344 — Topiramate, 68084-345 — Topiramate, 68382-004 — topiramate, 68382-005 — topiramate, 68382-138 — topiramate, 68382-140 — topiramate, 68382-141 — topiramate, 68382-358 — Topiramate, 68382-498 — topiramate, 68382-769 — Topiramate, 68382-863 — Topiramate, 68382-864 — Topiramate, 68462-108 — Topiramate, 68462-109 — Topiramate, 68462-110 — Topiramate, +289 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels